Oliver Fiehn

Director, NIH West Coast Metabolomics Center, Paul K & Ruth Stumpf Endowed Professor in Plant Biochemistry, UC Davis Genome Center, California, USA.

Motivation
I am motivated by novel discoveries – when a breakthrough technology opens new doors to avenues that people thought were impossible to travel! Metabolomics is one such “impossible” road, and I am glad many people are now exploring it.

What’s ahead for omics?
We are exploring personalized medicine not only on the level of cancer mutations, but also in the sense of individual differences in enzyme activities in people. We are all different, and we now have tools to utilize such differences. And we are finding many more “damage repair enzymes” by linking metabolomics with comparative genomics. Exciting!

Other categories: Mentors

Part of the Power List 2017

The Magnificent Tens
After 2016’s celebration of women in analytical science, we return to the Top 100 for 2017.
But there’s a twist. This summer, we asked you to nominate scientists in ten categories – from the stars of separation science, to omics explorers, to the mentors training the next generation.

Go to The Power List 2017